Abstract: Introduction: Infertility is a condition where a woman cannot conceive after unprotected sexual intercourse or therapeutic donor insemination for 12 months or six months for women under 35 years old or over 35 years old. It affects around 15% of marriages and is primarily caused by ovulatory disorders, endometriosis, pelvic adhesions, tubal blockage, and hyperprolactinemia. Treatments include melatonin, CoQ10, carnitine, selenium, vitamin D, myo-inositol, omega-3, Chinese herbs, and dietary interventions. Supplements like alpha lipoic acid and leucine are being explored as potential treatments for poor ovarian reserve, potentially reducing oxidative stress, improving mitochondrial function, regulating insulin sensitivity, and providing antioxidant benefits.
Materials and Methods: A study at the In Vitro Fertilization Center at Muzaffarnagar Medical College assessed the efficacy of Tab Eggtor, a proprietary supplement, in enhancing ovarian reserve and fertility in women with diminished ovarian function. The study involved 100 patients aged 25-35 who met inclusion criteria. Follow-up was performed after three months of daily Tab Eggtor administration.
Results: The study revealed significant increases in ovarian follicular counts and anti-Müllerian hormone levels between baseline and follow-up. The right ovary follicular count increased from 2.1 to 6.4 (p<0.00001), while the left ovary follicular count rose from 1.8 to 6.7. (p<0.00001) These findings suggest a significant development in ovarian follicle maturation over the observation period. The increase in Anti-Müllerian hormone levels (p=0.00091) suggested improved ovarian reserve and potential fertility.
Conclusion: The research demonstrated significant enhancements in ovarian follicular counts and Anti-Müllerian hormone levels, indicating enhanced ovarian function and fertility.
Indexed in Index Copernicus
